Glaxosmithkline Pharmaceuticals Ltd.
GLAXOHealthcareR1 raw held document library
Coverage
| Dataset | On disk | Usable | State |
|---|---|---|---|
| Results XBRL (NSE + BSE) | 93 | 33 | 33 quarter-ends |
| Annual reports | 11 | 11 | identity graded |
| Earnings calls | 3 | 3 | transcripts and analyst meets only |
| Shareholding | 19 | 19 | |
| Related party | 5 | 5 | |
| Investor decks | 0 | 0 | cohort of 48 companies only |
Financial statements in parse — expected 19 Sep 2026. Nothing from the superseded legacy store is shown.
Earnings calls
0 transcript(s)/analyst meet(s) served; 0 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 0 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| ANALYST_MEET | 20240808 | 2024-06-30 | yes | |
| ANALYST_MEET | 20241030 | 2024-09-30 | yes | |
| ANALYST_MEET | 20260806 | 2026-06-30 | yes |